O	O	0	9	Induction	Induction	B-NP	NN	O	0	ROOT	O
O	O	10	12	of	of	B-PP	IN	O	1	NMOD	O
T6	B-Entity	13	20	nuclear	nuclear	B-NP	JJ	B-protein	6	NMOD	B-protein
T6	I-Entity	21	27	factor	factor	I-NP	NN	I-protein	6	NMOD	I-protein
T6	I-Entity	28	33	kappa	kappa	I-NP	NN	I-protein	6	NMOD	I-protein
T6	I-Entity	34	35	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
T6	I-Entity	35	36	/	/	B-NP	SYM	O	10	NMOD	O
T6	I-Entity	36	39	Rel	Rel	I-NP	NN	B-protein	10	NMOD	B-protein
O	O	40	47	nuclear	nuclear	I-NP	JJ	O	10	NMOD	O
O	O	48	56	activity	activity	I-NP	NN	O	2	PMOD	O
O	O	57	59	in	in	B-PP	IN	O	1	NMOD	O
O	O	60	65	human	human	B-NP	JJ	B-cell_type	16	NMOD	B-cell_type
O	O	66	76	peripheral	peripheral	I-NP	JJ	I-cell_type	16	NMOD	I-cell_type
O	O	77	82	blood	blood	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	83	84	T	T	I-NP	NN	I-cell_type	16	NMOD	I-cell_type
O	O	85	96	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	11	PMOD	I-cell_type
O	O	97	99	by	by	B-PP	IN	O	1	NMOD	O
O	O	100	104	anti	anti	B-NP	AFX	O	24	NMOD	O
O	O	104	105	-	-	I-NP	HYPH	O	24	P	O
O	O	105	108	HLA	HLA	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	109	114	class	class	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	115	116	I	I	I-NP	CD	I-protein	24	NMOD	I-protein
O	O	117	127	monoclonal	monoclonal	I-NP	JJ	I-protein	24	NMOD	I-protein
O	O	128	138	antibodies	antibody	I-NP	NNS	I-protein	17	PMOD	I-protein
O	O	138	139	.	.	O	.	O	1	P	O

O	O	141	151	Monoclonal	Monoclonal	B-NP	JJ	B-protein	2	NMOD	B-protein
O	O	152	162	antibodies	antibody	I-NP	NNS	I-protein	23	NMOD	I-protein
O	O	163	170	against	against	B-PP	IN	O	2	NMOD	O
O	O	171	177	either	either	B-NP	CC	O	8	NMOD	O
O	O	178	189	monomorphic	monomorphic	I-NP	JJ	O	8	NMOD	O
O	O	190	192	or	or	I-NP	CC	O	8	NMOD	O
O	O	193	204	polymorphic	polymorphic	I-NP	JJ	O	8	NMOD	O
T7	B-Entity	205	217	determinants	determinant	I-NP	NNS	O	3	PMOD	O
O	O	218	220	of	of	B-PP	IN	O	8	NMOD	O
O	O	221	226	class	class	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	227	228	I	I	I-NP	CD	I-protein	12	NMOD	I-protein
O	O	229	236	antigen	antigen	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	237	244	induced	induce	B-VP	VBN	O	12	NMOD	O
O	O	245	247	in	in	B-PP	IN	O	13	VMOD	O
O	O	248	252	PBMC	PBMC	B-NP	NN	B-cell_type	17	NMOD	B-cell_type
O	O	253	256	and	and	O	CC	O	17	NMOD	O
O	O	257	263	highly	highly	B-NP	RB	O	18	AMOD	O
O	O	264	272	purified	purify	I-NP	VBN	O	20	NMOD	O
O	O	273	274	T	T	I-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	275	286	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	287	290	the	the	B-NP	DT	O	23	NMOD	O
O	O	291	298	nuclear	nuclear	I-NP	JJ	O	23	NMOD	O
O	O	299	307	activity	activity	I-NP	NN	O	0	ROOT	O
O	O	308	310	of	of	B-PP	IN	O	23	NMOD	O
T8	B-Entity	311	313	NF	NF	B-NP	NN	B-protein	28	NMOD	B-protein
T8	I-Entity	313	314	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T8	I-Entity	314	319	kappa	kappa	I-NP	NN	I-protein	28	NMOD	I-protein
T8	I-Entity	320	321	B	B	I-NP	NN	I-protein	31	NMOD	I-protein
T8	I-Entity	321	322	/	/	B-NP	SYM	O	31	P	O
T8	I-Entity	322	325	Rel	Rel	I-NP	NN	B-protein	31	NMOD	B-protein
T8	I-Entity	326	335	complexes	complex	I-NP	NNS	I-protein	24	PMOD	I-protein
O	O	335	336	.	.	O	.	O	23	P	O

O	O	337	342	These	These	B-NP	DT	O	2	SUB	O
O	O	343	351	included	include	B-VP	VBD	O	0	ROOT	O
O	O	352	356	both	both	O	CC	O	11	NMOD	O
T1	B-Protein	357	360	p50	p50	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	360	361	/	/	B-NP	SYM	O	11	NMOD	O
T2	B-Protein	361	364	p50	p50	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	365	368	and	and	O	CC	O	11	NMOD	O
T3	B-Protein	369	372	p50	p50	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	372	373	/	/	O	SYM	O	11	P	O
T4	B-Protein	373	376	p65	p65	B-NP	NN	B-protein	11	NMOD	B-protein
T9	B-Entity	377	383	dimers	dimer	I-NP	NNS	I-protein	2	OBJ	I-protein
O	O	383	384	,	,	O	,	O	11	P	O
O	O	385	395	recognized	recognize	B-VP	VBN	O	11	NMOD	O
O	O	396	398	by	by	B-PP	IN	O	13	VMOD	O
O	O	399	407	specific	specific	B-NP	JJ	B-protein	16	NMOD	B-protein
O	O	408	418	antibodies	antibody	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	419	421	in	in	B-PP	IN	O	16	NMOD	O
O	O	422	426	EMSA	EMSA	B-NP	NN	O	17	PMOD	O
O	O	426	427	.	.	O	.	O	2	P	O

O	O	428	431	The	The	B-NP	DT	O	3	NMOD	O
O	O	432	439	induced	induce	I-NP	VBN	O	3	NMOD	O
O	O	440	449	complexes	complex	I-NP	NNS	O	4	SUB	O
O	O	450	454	were	be	B-VP	VBD	O	29	VMOD	O
O	O	455	465	detectable	detectable	B-ADJP	JJ	O	4	PRD	O
O	O	466	468	in	in	B-PP	IN	O	5	AMOD	O
O	O	469	477	extracts	extract	B-NP	NNS	O	6	PMOD	O
O	O	478	480	of	of	B-PP	IN	O	7	NMOD	O
O	O	481	486	cells	cell	B-NP	NNS	O	8	PMOD	O
O	O	487	496	incubated	incubate	B-VP	VBN	O	9	NMOD	O
O	O	497	501	with	with	B-PP	IN	O	10	VMOD	O
O	O	502	506	anti	anti	B-NP	AFX	B-protein	17	NMOD	B-protein
O	O	506	507	-	-	I-NP	HYPH	I-protein	17	NMOD	I-protein
O	O	507	512	class	class	B-NP	NN	I-protein	17	NMOD	I-protein
O	O	513	514	I	I	I-NP	CD	I-protein	17	NMOD	I-protein
O	O	515	525	monoclonal	monoclonal	I-NP	JJ	I-protein	17	NMOD	I-protein
O	O	526	534	antibody	antibody	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	535	536	(	(	O	(	O	20	DEP	O
O	O	536	539	mAb	mAb	B-NP	NN	B-protein	20	DEP	B-protein
O	O	539	540	)	)	O	)	O	17	NMOD	O
O	O	541	544	for	for	B-PP	IN	O	10	VMOD	O
O	O	545	546	1	1	B-NP	CD	O	25	NMOD	O
O	O	546	547	.	.	O	.	O	25	NMOD	O
O	O	547	548	5	5	B-NP	CD	O	25	NMOD	O
O	O	549	550	h	h	I-NP	NN	O	21	PMOD	O
O	O	550	551	;	;	O	:	O	29	P	O
O	O	552	555	the	the	B-NP	DT	O	28	NMOD	O
O	O	556	565	induction	induction	I-NP	NN	O	29	SUB	O
O	O	566	569	was	be	B-VP	VBD	O	0	ROOT	O
O	O	570	577	maximal	maximal	B-ADJP	JJ	O	29	VMOD	O
O	O	578	580	at	at	B-PP	IN	O	30	AMOD	O
O	O	581	582	5	5	B-NP	CD	O	33	NMOD	O
O	O	583	584	h	h	I-NP	NN	O	31	PMOD	O
O	O	584	585	,	,	O	,	O	30	P	O
O	O	586	596	persistent	persistent	B-ADJP	JJ	O	30	PRD	O
O	O	597	599	at	at	B-PP	IN	O	35	AMOD	O
O	O	600	602	16	16	B-NP	CD	O	38	NMOD	O
O	O	603	604	h	h	I-NP	NN	O	36	PMOD	O
O	O	605	608	and	and	O	CC	O	30	DEP	O
O	O	609	611	no	no	B-ADVP	RB	O	41	AMOD	O
O	O	612	618	longer	longer	I-ADVP	RBR	O	42	VMOD	O
O	O	619	627	observed	observe	B-VP	VBN	O	30	DEP	O
O	O	628	630	at	at	B-PP	IN	O	42	VMOD	O
O	O	631	633	40	40	B-NP	CD	O	45	NMOD	O
O	O	634	635	h	h	I-NP	NN	O	43	PMOD	O
O	O	635	636	.	.	O	.	O	29	P	O

O	O	637	640	The	The	B-NP	DT	O	2	NMOD	O
O	O	641	644	mAb	mAb	I-NP	NN	B-protein	3	SUB	B-protein
O	O	645	651	failed	fail	B-VP	VBD	O	0	ROOT	O
O	O	652	654	to	to	I-VP	TO	O	5	VMOD	O
O	O	655	661	induce	induce	I-VP	VB	O	3	VMOD	O
T10	B-Entity	662	664	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T10	I-Entity	664	665	-	-	B-NP	HYPH	I-protein	9	NMOD	I-protein
T10	I-Entity	665	670	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T10	I-Entity	671	672	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	672	673	/	/	B-NP	SYM	O	13	NMOD	O
O	O	673	676	Rel	Rel	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	677	684	nuclear	nuclear	I-NP	JJ	O	13	NMOD	O
O	O	685	693	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	694	696	in	in	B-PP	IN	O	13	NMOD	O
O	O	697	702	cells	cell	B-NP	NNS	O	14	PMOD	O
O	O	703	712	incubated	incubate	B-VP	VBN	O	15	NMOD	O
O	O	713	715	in	in	B-PP	IN	O	16	VMOD	O
O	O	716	719	the	the	B-NP	DT	O	19	NMOD	O
O	O	720	728	presence	presence	I-NP	NN	O	17	PMOD	O
O	O	729	731	of	of	B-PP	IN	O	19	NMOD	O
O	O	732	733	3	3	B-NP	CD	O	28	NMOD	O
O	O	733	734	,	,	I-NP	,	O	28	P	O
O	O	734	735	4	4	I-NP	CD	O	25	NMOD	O
O	O	735	736	-	-	I-NP	HYPH	O	25	NMOD	O
O	O	736	755	dichloroisocoumarin	dichloroisocoumarin	I-NP	NN	O	28	NMOD	O
O	O	755	756	,	,	O	,	O	28	P	O
O	O	757	759	an	an	B-NP	DT	O	28	NMOD	O
O	O	760	769	inhibitor	inhibitor	I-NP	NN	O	35	NMOD	O
O	O	770	772	of	of	B-PP	IN	O	28	NMOD	O
T5	B-Protein	773	774	I	I	B-NP	NN	B-protein	32	NMOD	B-protein
T5	I-Protein	775	780	kappa	kappa	I-NP	NN	I-protein	32	NMOD	I-protein
T5	I-Protein	781	782	B	B	I-NP	NN	I-protein	29	PMOD	I-protein
T5	I-Protein	782	783	-	-	O	HYPH	O	35	NMOD	O
T5	I-Protein	783	788	alpha	alpha	B-NP	SYM	O	35	NMOD	O
O	O	789	800	degradation	degradation	I-NP	NN	O	20	PMOD	O
O	O	800	801	.	.	O	.	O	3	P	O

O	O	802	810	Together	Together	B-ADVP	RB	O	5	VMOD	O
O	O	810	811	,	,	O	,	O	5	P	O
O	O	812	817	these	these	B-NP	DT	O	4	NMOD	O
O	O	818	825	results	result	I-NP	NNS	O	5	SUB	O
O	O	826	833	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	834	838	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	839	844	class	class	B-NP	NN	O	9	NMOD	O
O	O	845	846	I	I	I-NP	CD	O	9	NMOD	O
O	O	847	857	triggering	triggering	I-NP	NN	O	10	SUB	O
O	O	858	861	can	can	B-VP	MD	O	6	SBAR	O
O	O	862	868	induce	induce	I-VP	VB	O	10	VC	O
O	O	869	872	the	the	B-NP	DT	O	13	NMOD	O
O	O	873	881	activity	activity	I-NP	NN	O	11	OBJ	O
O	O	882	884	of	of	B-PP	IN	O	13	NMOD	O
T11	B-Entity	885	887	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
T11	I-Entity	887	888	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T11	I-Entity	888	893	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
T11	I-Entity	894	895	B	B	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	895	896	/	/	B-NP	SYM	O	22	P	O
O	O	896	899	Rel	Rel	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	900	907	nuclear	nuclear	I-NP	JJ	O	22	NMOD	O
O	O	908	916	activity	activity	I-NP	NN	O	14	PMOD	O
O	O	917	919	in	in	B-PP	IN	O	22	NMOD	O
O	O	920	930	peripheral	peripheral	B-NP	JJ	B-cell_type	27	NMOD	B-cell_type
O	O	931	936	blood	blood	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	937	938	T	T	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	939	950	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	950	951	,	,	O	,	O	10	P	O
O	O	952	959	thereby	thereby	B-VP	RB	O	30	VMOD	O
O	O	960	970	modulating	modulate	I-VP	VBG	O	10	VMOD	O
O	O	971	974	the	the	B-NP	DT	O	32	NMOD	O
O	O	975	985	expression	expression	I-NP	NN	O	30	OBJ	O
O	O	986	988	of	of	B-PP	IN	O	32	NMOD	O
T12	B-Entity	989	994	genes	gene	B-NP	NNS	O	33	PMOD	O
O	O	995	1004	regulated	regulate	B-VP	VBN	O	34	NMOD	O
O	O	1005	1007	by	by	B-PP	IN	O	35	VMOD	O
O	O	1008	1013	these	these	B-NP	DT	O	39	NMOD	O
O	O	1014	1027	transcription	transcription	I-NP	NN	B-protein	39	NMOD	B-protein
O	O	1028	1035	factors	factor	I-NP	NNS	I-protein	36	PMOD	I-protein
O	O	1035	1036	.	.	O	.	O	5	P	O
